Published by Josh White on 12th December 2023
(Sharecast News) - Cell engineering technology specialist MaxCyte announced a significant chief executive transition on Tuesday and updated its revenue guidance for 2023.
URL: http://www.digitallook.com/dl/news/story/33966874/...